SCHEMBL659513

SCHEMBL659513

C=C(C=O)c1ccoc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27483243 0.76
SCHEMBL8865985 0.74 TRPA1 (0.39)
SCHEMBL27514010 0.72 TRPA1 (0.41)
SCHEMBL8253505 0.72
SCHEMBL17269511 0.70
SCHEMBL10369956 0.70
SCHEMBL564791 0.70 MAPT (0.44)
SCHEMBL2260835 0.70
Trimethylammonium SCHEMBL28780678 0.69 MAPT (0.49)
SCHEMBL8866037 0.69 TRPA1 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2432864-B1 PROCESS TO PRODUCE A WINE OR FRUIT JUICE STABILISER RYMCO INT AG (CH) 2018-11-14 EP disclosed
EP-2432864-A2 PROCESS TO PRODUCE A WINE OR FRUIT JUICE STABILISER DSM IP Assets B.V. (NL) 2012-03-28 EP disclosed
US-20120045542-A1 PROCESS TO PRODUCE A WINE OR FRUIT JUICE STABLISER DSM IP ASSETS B.V. (NL) 2012-02-23 US disclosed
WO-2010133543-A2 PROCESS TO PRODUCE A WINE OR FRUIT JUICE STABILISER DSM IP ASSETS B.V. (NL) 2010-11-25 WO disclosed
US-7833998-B2 Oral neurotherapeutic cephalosporin sulfoxide and sulfone-containing compositions REVAAX PHARMACEUTICALS, LLC (US) 2010-11-16 US disclosed
US-20080176825-A1 Oral Neurotherapeutic Cefazolin Compositons REVAAX PHARMACEUTICALS, LLC 2008-07-24 US disclosed
WO-2005117595-A1 METHOD TO IMPROVE FLAVOUR OF BAKED CEREAL PRODUCTS DSM IP ASSETS B.V. (NL) 2005-12-15 WO disclosed
EP-0320628-A1 Substituted furan compounds which are useful in inhibiting lipoxygenase enzymes, particularly 5-lipoxygenase ABBOTT LABORATORIES (US) 1989-06-21 EP disclosed